D M Moore

Summary

Affiliation: British Columbia
Country: Canada

Publications

  1. pmc Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial
    Jonathan Mermin
    Global AIDS Program, Centers for Disease Control and Prevention Uganda, Entebbe, Uganda
    BMJ 343:d6792. 2011
  2. pmc Risks for HIV and other sexually transmitted infections among Asian men who have sex with men in Vancouver, British Columbia: a cross-sectional survey
    Thiha Maung Maung
    Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada
    BMC Public Health 13:763. 2013
  3. ncbi Implications for HIV prevention programs from a serobehavioural survey of men who have sex with men in Vancouver, British Columbia: the ManCount study
    David M Moore
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, BC
    Can J Public Health 103:142-6. 2012
  4. ncbi Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda
    David Moore
    Global AIDS Program, Us centers for Disease Control and Prevention CDC, Entebbe, Uganda
    AIDS 21:713-9. 2007
  5. doi Monitoring antiretroviral failure in resource-poor settings
    David M Moore
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, BC, Canada, V6T 1Y6
    Lancet 371:1396-7. 2008
  6. doi CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy
    David M Moore
    Global AIDS Program, US Centers for Disease Control and Prevention, Entebbe, Uganda
    J Acquir Immune Defic Syndr 49:477-84. 2008
  7. pmc Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression
    David M Moore
    Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    J Acquir Immune Defic Syndr 52:357-63. 2009
  8. ncbi Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme
    D M Moore
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    HIV Med 11:299-307. 2010
  9. pmc Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda
    David M Moore
    Global AIDS Program, Us centers for Disease Control and Prevention CDC, Entebbe, Uganda
    J Acquir Immune Defic Syndr 58:289-96. 2011
  10. pmc Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study
    Siavash Jafari
    British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, Vancouver, Canada
    AIDS Res Ther 8:31. 2011

Collaborators

Detail Information

Publications32

  1. pmc Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial
    Jonathan Mermin
    Global AIDS Program, Centers for Disease Control and Prevention Uganda, Entebbe, Uganda
    BMJ 343:d6792. 2011
    ..To evaluate the use of routine laboratory monitoring in terms of clinical outcomes among patients receiving antiretroviral therapy (ART) in Uganda...
  2. pmc Risks for HIV and other sexually transmitted infections among Asian men who have sex with men in Vancouver, British Columbia: a cross-sectional survey
    Thiha Maung Maung
    Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada
    BMC Public Health 13:763. 2013
    ..Approximately 10% of the new HIV diagnoses in men in British Columbia occur among Asian-Canadians. However, the HIV risk patterns of Asian men who have sex with men (MSM) have not been extensively studied...
  3. ncbi Implications for HIV prevention programs from a serobehavioural survey of men who have sex with men in Vancouver, British Columbia: the ManCount study
    David M Moore
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, BC
    Can J Public Health 103:142-6. 2012
    ..We examined HIV prevalence, awareness of HIV serostatus and HIV risk behaviour among a sample of men who have sex with men (MSM) in Vancouver...
  4. ncbi Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda
    David Moore
    Global AIDS Program, Us centers for Disease Control and Prevention CDC, Entebbe, Uganda
    AIDS 21:713-9. 2007
    ..Tuberculosis (TB) is the leading cause of death among people with HIV in sub-Saharan Africa. Expanding access to antiretroviral therapy (ART) may reduce the burden of TB, but to what extent is unknown...
  5. doi Monitoring antiretroviral failure in resource-poor settings
    David M Moore
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, BC, Canada, V6T 1Y6
    Lancet 371:1396-7. 2008
  6. doi CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy
    David M Moore
    Global AIDS Program, US Centers for Disease Control and Prevention, Entebbe, Uganda
    J Acquir Immune Defic Syndr 49:477-84. 2008
    ..However, the utility of such monitoring in terms of predicting virologic response to therapy has been little studied...
  7. pmc Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression
    David M Moore
    Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    J Acquir Immune Defic Syndr 52:357-63. 2009
    ..However, the effects of immunologic responses, whether measured as CD4 count changes from baseline or CD4 counts at follow-up, in patients with virologic suppression, have not been clearly established...
  8. ncbi Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme
    D M Moore
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    HIV Med 11:299-307. 2010
    ..We examined clinical outcomes, patient characteristics and trends over time of non-medically supervised treatment interruptions (TIs) from a free-of-charge antiretroviral therapy (ART) programme in British Columbia (BC), Canada...
  9. pmc Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda
    David M Moore
    Global AIDS Program, Us centers for Disease Control and Prevention CDC, Entebbe, Uganda
    J Acquir Immune Defic Syndr 58:289-96. 2011
    ..Understanding the clinical conditions associated with mortality could potentially lead to effective interventions to prevent these deaths...
  10. pmc Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study
    Siavash Jafari
    British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, Vancouver, Canada
    AIDS Res Ther 8:31. 2011
    ..abstract:..
  11. ncbi Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings
    David M Moore
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
    J Acquir Immune Defic Syndr 43:436-9. 2006
    ..The performance of immunologic monitoring for this purpose has not been evaluated, however...
  12. ncbi Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy
    D M Moore
    BC Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
    HIV Med 7:311-6. 2006
    ....
  13. ncbi CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microL
    D M Moore
    BC Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
    HIV Med 7:383-8. 2006
    ..To determine the prognostic value of baseline CD4 percentage in terms of patient survival in comparison to absolute CD4 cell counts for HIV-positive patients initiating highly active antiretroviral therapy (HAART)...
  14. ncbi Protecting health care workers from SARS and other respiratory pathogens: organizational and individual factors that affect adherence to infection control guidelines
    David Moore
    Occupational Health and Safety Agency for Healthcare in British Columbia, Canada
    Am J Infect Control 33:88-96. 2005
    ....
  15. ncbi Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy
    David M Moore
    BC Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
    Antivir Ther 11:125-9. 2006
    ..We designed a study to determine whether risks for later mortality are similar for HCV-positive and HCV-negative individuals when subjects are stratified on the basis of baseline CD4+ T-cell counts...
  16. ncbi Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy
    David M Moore
    British Columbia Centre for Excellence in HIV AIDS, 608 1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6
    J Acquir Immune Defic Syndr 40:288-93. 2005
    ..To examine the independent association of discordant virologic and immunologic responses to highly active antiretroviral therapy (HAART) with mortality...
  17. ncbi Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response
    David M Moore
    BC Centre for Excellence in HIV AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    AIDS 20:371-7. 2006
    ..To determine if immunological response is associated with disease progression in patients with virological suppression after initiating HAART...
  18. doi The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis
    M Murray
    Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada
    HIV Med 13:89-97. 2012
    ..We examined whether determinants of disease progression and causes of death differ between injecting drug users (IDUs) and non-IDUs who initiate combination antiretroviral therapy (cART)...
  19. ncbi Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program
    Paula Braitstein
    British Columbia Centre for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
    J Infect Dis 193:259-68. 2006
    ..We sought to characterize the impact that hepatitis C virus (HCV) infection has on CD4 cells during the first 48 weeks of antiretroviral therapy (ART) in previously ART-naive human immunodeficiency virus (HIV)-infected patients...
  20. ncbi Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
    Viviane D Lima
    BC Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    AIDS 21:685-92. 2007
    ..To characterize the temporal changes in mortality and life expectancy among HIV-positive individuals initiating antiretroviral therapy in British Columbia, Canada, from 1993 to 2004...
  21. ncbi A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility
    Thomas Kerr
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
    Int J Drug Policy 18:37-45. 2007
    ..Safer injection facilities (SIFs) constitute one such intervention, although little is known about the impact of such facilities on factors that mediate risk for overdose...
  22. ncbi Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl
    Evan Wood
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 667 1081 Burrard Street, Vancouver, BC, Canada
    AIDS 20:1117-23. 2006
    ..There is uncertainty regarding the optimal strategy for patients with high plasma HIV RNA but CD4 cell count > or = 200 cells/microl...
  23. pmc Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study
    Jaco Homsy
    Centers for Disease Control and Prevention, Global AIDS Program, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Entebbe, Uganda
    PLoS ONE 4:e4149. 2009
    ..71 per 10-year decrease, 95% CI: 2.95-3.78), having a BMI>18.5 (HR = 1.09, CI: 1.01-1.18) and not having used condoms consistently in the last 3 months (HR = 1.79, CI: 1.02-3.13) were independently associated with pregnancy...
  24. ncbi Back to work: correlates of employment among persons receiving highly active antiretroviral therapy
    Marcus Lem
    University of British Columbia, Canada
    AIDS Care 17:740-6. 2005
    ..In conclusion, our study demonstrates that while significant advances have been made in the reduction of HIV-related mortality, the majority of HIV-infected individuals on adequate treatment are still unable to be gainfully employed...
  25. ncbi Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature
    Bruce Gamage
    British Columbia Centre for Disease Control, Vancouver, BC, Canada
    Am J Infect Control 33:114-21. 2005
    ..SARS focused attention on the adequacy of and compliance with infection control practices in preventing airborne and droplet-spread transmission of infectious agents...
  26. ncbi Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition
    Stevens Bechange
    CDC Uganda, Global AIDS Program, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Uganda Virus Research Institute, Centers for Disease Control and Prevention CDC, Entebbe, Uganda
    AIDS Behav 14:816-23. 2010
    ..No evidence of behavioral disinhibition was observed. Concerns regarding behavioral disinhibition should not slow down efforts to increase ART access in Africa...
  27. doi Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study
    Jonathan Mermin
    Centers for Disease Control and Prevention Uganda, Global AIDS Program, National Center for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Entebbe, Uganda
    Lancet 371:752-9. 2008
    ..We therefore assessed the effect of a home-based ART programme in Uganda on mortality, hospital admissions, and orphanhood in people with HIV-1 and their household members...
  28. ncbi Total lymphocyte counts and ART in resource-limited settings
    David Moore
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada V6Z 1Y6
    Lancet 366:1831-2. 2005
  29. ncbi Trends in antenatal human immunodeficiency virus prevalence in Western Kenya and Eastern Uganda: evidence of differences in health policies?
    David M Moore
    Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC, Canada
    Int J Epidemiol 33:542-8. 2004
    ..Design An ecologic study was conducted at the district level comparing HIV prevalence rates over time using data available through reports published by the Kenyan and Ugandan Ministries of Health and UNAIDS...
  30. ncbi Occupational health and infection control practices related to severe acute respiratory syndrome: health care worker perceptions
    David M Moore
    Occupational Health and Safety Agency for Health Care in British Columbia, Vancouver, British Columbia, Canada
    AAOHN J 53:257-66. 2005
    ....
  31. doi Antiretroviral therapy improves renal function among HIV-infected Ugandans
    Philip J Peters
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Kidney Int 74:925-9. 2008
    ..Our study shows that renal dysfunction was common with advanced HIV disease in Uganda but this improved following 2 years of HAART...